]>
IRCT2015122025618N1 IRCT 2016-01-25 shiraz universirty of medical sciences the effect of cinnamon on lipid and blood sugar in polycystic ovary syndrome effect of cinnamon powder capsule on some of lipid and blood sugar profile in overweight or obese women with polycystic ovary syndrome 2016-01-03 anticipated 62 Complete https://irct.ir/trial/21387 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment. N/A polycystic ovary syndrome. Intervention 1: the intervention group use cinnamon powder capsules three times a day and each time two 500- milligram capsules(a total of 3 grams per day) orally for two months. Intervention 2: control group use cellulose capsule three times a day and each time two 500-miligram capsules (a total of three grams per day) orally for two months.
public Zeinab Moshfeghy
Fatemeh School of Nursing and Midwifery،Namazi Square
Shiraz Iran (Islamic Republic of) +98 71 3647 4252 zmoshfeghy1385@yahoo.com Fatemeh School of Nursing and Midwifery، Shiraz University of Medical Sciences scientific Zeinab Moshfeghy
Fatemeh School of Nursing and Midwifery،Namazi Square
Shiraz Iran (Islamic Republic of) +98 71 3647 4252 zmoshfeghy1385@yahoo.com Fatemeh School of Nursing and Midwifery،Shiraz Universty of Medical Sciences Iran (Islamic Republic of) Iran (Islamic Republic of) Iran (Islamic Republic of) inclusion criteria:people who want to participate in study and full fill the informed consent form;Before choosing the sample, polycystic ovarian syndrome diagnosed by the gynecologist based on Rotterdam criteria;people have body mass index 25 or more;people age range is between18-40;have not Previous history of allergy to cinnamon consumption;do not have hypertension;do not have diabetes mellitus;do not have cardio vascular disease;do not have hepatic disease;do not have renal disease;do not have Cerebrovascular disease;do not have Seizure disorders;do not have Increased levels of the prolactin or other endocrine disorders;do not have Hypothyroidism or hyperthyroidism;do not have adrenal disorders;do not have cancer;do not have infertility;do not have history of alcohol use or smoking;do not use hormone therapy during three months prior to study;do not use hormonal contraception during three months prior to study;do not use insulin sensitizing drug during three months prior to study;do not be during pregnancy or breast feeding period; exclusion criteria do not want to continue the study;In case of any allergic symptoms after taking cinnamon;cinnamon consumption cut and will be excluded;In the event of pregnancy;cinnamon consumption cut and will be excluded;In case of loss of any inclusion criteria drug use will be cut and people excluded from the study 18 years 40 years Female E28.2 Sclerocystic ovary syndromeStein-Leventhal syndrome Treatment - Drugs Placebo the intervention group use cinnamon powder capsules three times a day and each time two 500- milligram capsules(a total of 3 grams per day) orally for two months control group use cellulose capsule three times a day and each time two 500-miligram capsules (a total of three grams per day) orally for two months Body mass index. Timepoint: before intervention and after intervention. Method of measurement: Kilograms per height in square meters by the formula. Weight. Timepoint: before study and after study. Method of measurement: kilogram by using scale. Height. Timepoint: before intervention and after intervention. Method of measurement: centimetre by using metre. Fasting glucose. Timepoint: before intervention and after intervention. Method of measurement: Milligrams per deciliter by use blood samples and laboratory testing. Fasting insulin. Timepoint: before intervention and after intervention. Method of measurement: Micro units per milliliters of blood samples and laboratory testing. Insulin resistance. Timepoint: before intervention and after intervention. Method of measurement: by using formula. Oral glucose tolerance test. Timepoint: before intervention and after intervention. Method of measurement: Milligrams per deciliter by using blood sample and laboratory testing. Cholesterol. Timepoint: before and after intervention. Method of measurement: Milligrams per deciliter by using blood samples and laboratory testing. Low density lipoprotein. Timepoint: before and after intervention. Method of measurement: Milligrams per deciliter by using blood samples and laboratory testing. High density lipoprotein. Timepoint: before and after intervention. Method of measurement: Milligrams per deciliter by using blood samples and laboratory testing. Triglyceride. Timepoint: before and after intervention. Method of measurement: Milligrams per deciliter by using blood samples and laboratory testing. Abdominal pain. Timepoint: before and during and after intervention. Method of measurement: Periodic follow-up by telephone call. Itching. Timepoint: before and during and after intervention. Method of measurement: Periodic follow-up by telephone call. Headache. Timepoint: before and during and after intervention. Method of measurement: Periodic follow-up by telephone call. Hives. Timepoint: before and during and after intervention. Method of measurement: Periodic follow-up by telephone call. Asthma. Timepoint: before and during and after intervention. Method of measurement: Periodic follow-up by telephone call. Respiratory allergies. Timepoint: before and during and after intervention. Method of measurement: Periodic follow-up by telephone call. Diarrhea. Timepoint: before and during and after intervention. Method of measurement: Periodic follow-up by telephone call. Nausea. Timepoint: before and during and after intervention. Method of measurement: Periodic follow-up by telephone call. Heartburn. Timepoint: before and during and after intervention. Method of measurement: Periodic follow-up by telephone call. shiraz universirty of medical sciences Approved 2015-12-16 Shiraz University of Medical Sciences Central Building of Shiraz University of Medical Sciences,Zand Street, Shiraz Shiraz Iran (Islamic Republic of)